These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10220029)

  • 1. Synthesis of an antisense oligonucleotide targeted against C-raf kinase: efficient oligonucleotide synthesis without chlorinated solvents.
    Krotz AH; Cole DL; Ravikumar VT
    Bioorg Med Chem; 1999 Mar; 7(3):435-9. PubMed ID: 10220029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence-specific antitumor activity of a phosphorothioate oligodeoxyribonucleotide targeted to human C-raf kinase supports an antisense mechanism of action in vivo.
    Monia BP; Sasmor H; Johnston JF; Freier SM; Lesnik EA; Muller M; Geiger T; Altmann KH; Moser H; Fabbro D
    Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15481-4. PubMed ID: 8986837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreous anti-raf-1 kinase antisense oligonucleotide as an angioinhibitory agent in porcine preretinal neovascularization.
    Danis R; Criswell M; Orge F; Wancewicz E; Stecker K; Henry S; Monia B
    Curr Eye Res; 2003 Jan; 26(1):45-54. PubMed ID: 12789536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and cellular characterization of baboon C-Raf as a target for antiproliferative effects of antisense oligonucleotides.
    Mandiyan S; Schumacher C; Cioffi C; Sharif H; Yuryev A; Lappe R; Monia B; Hanson S; Goff S; Wennogle L
    Antisense Nucleic Acid Drug Dev; 1997 Dec; 7(6):539-48. PubMed ID: 9450911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense phosphorothioate oligodeoxyribonucleotide targeted against ICAM-1: synthetic and biological characterization of a process-related impurity formed during oligonucleotide synthesis.
    Ravikumar VT; Capaldi DC; Lima WF; Lesnik E; Turney B; Cole DL
    Bioorg Med Chem; 2003 Oct; 11(21):4673-9. PubMed ID: 14527564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First- and second-generation antisense oligonucleotide inhibitors targeted against human c-raf kinase.
    Monia BP
    Ciba Found Symp; 1997; 209():107-19; discussion 119-23. PubMed ID: 9383572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of antisense oligonucleotides with minimum depurination.
    Krotz AH; Cole DL; Ravikumar VT
    Nucleosides Nucleotides Nucleic Acids; 2003 Feb; 22(2):129-34. PubMed ID: 12744600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I trial of c-Raf kinase antisense oligonucleotide ISIS 5132 administered as a continuous intravenous infusion in patients with advanced cancer.
    Cunningham CC; Holmlund JT; Schiller JH; Geary RS; Kwoh TJ; Dorr A; Nemunaitis J
    Clin Cancer Res; 2000 May; 6(5):1626-31. PubMed ID: 10815879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2'-O-[2-[(N,N-dimethylamino)oxy]ethyl]-modified oligonucleotides inhibit expression of mRNA in vitro and in vivo.
    Prakash TP; Johnston JF; Graham MJ; Condon TP; Manoharan M
    Nucleic Acids Res; 2004; 32(2):828-33. PubMed ID: 14762210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of high quality phosphorothioate oligonucleotides as antisense drugs. Use of I-linker in the elimination of 3'-terminal phosphorothioate monoesters.
    Ravikumar VT; Kumar RK; Capaldi DC; Cole DL
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1421-5. PubMed ID: 14565433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I Trial of ISIS 5132, an antisense oligonucleotide inhibitor of c-raf-1, administered by 24-hour weekly infusion to patients with advanced cancer.
    Rudin CM; Holmlund J; Fleming GF; Mani S; Stadler WM; Schumm P; Monia BP; Johnston JF; Geary R; Yu RZ; Kwoh TJ; Dorr FA; Ratain MJ
    Clin Cancer Res; 2001 May; 7(5):1214-20. PubMed ID: 11350886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of 4,4'-dimethoxytrityl-C-phosphonate oligonucleotides.
    Capaldi DC; Gaus HJ; Carty RL; Moore MN; Turney BJ; Decottignies SD; McArdle JV; Scozzari AN; Ravikumar VT; Krotz AH
    Bioorg Med Chem Lett; 2004 Sep; 14(18):4683-90. PubMed ID: 15324888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New standards in LNA synthesis.
    Hansen HF; Olsen O; Koch T
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1273-5. PubMed ID: 14565397
    [No Abstract]   [Full Text] [Related]  

  • 14. Toward antisense oligonucleotide therapy for cancer: ISIS compounds in clinical development.
    Holmlund JT; Monia BP; Kwoh TJ; Dorr FA
    Curr Opin Mol Ther; 1999 Jun; 1(3):372-85. PubMed ID: 11713802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo pro-apoptotic and antitumor efficacy of a c-Raf antisense phosphorothioate oligonucleotide: relationship to tumor size.
    Lau QC; Achenbach TV; Borchers O; Müller R; Slater EP
    Antisense Nucleic Acid Drug Dev; 2002 Feb; 12(1):11-20. PubMed ID: 12022686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mild and efficient solid-support synthesis of novel oligonucleotide conjugates.
    Habus I; Xie J; Iyer RP; Zhou WQ; Shen LX; Agrawal S
    Bioconjug Chem; 1998; 9(2):283-91. PubMed ID: 9548546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of A-Raf and C-Raf mRNA expression by antisense oligodeoxynucleotides in rat vascular smooth muscle cells: role of A-Raf and C-Raf in serum-induced proliferation.
    Cioffi CL; Garay M; Johnston JF; McGraw K; Boggs RT; Hreniuk D; Monia BP
    Mol Pharmacol; 1997 Mar; 51(3):383-9. PubMed ID: 9058592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAF antisense oligonucleotide as a tumor radiosensitizer.
    Kasid U; Dritschilo A
    Oncogene; 2003 Sep; 22(37):5876-84. PubMed ID: 12947394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A short, novel, and cheaper procedure for oligonucleotide synthesis using automated solid phase synthesizer.
    Song Q; Wang Z; Sanghvi YS
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):629-33. PubMed ID: 14565241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis in solution of oligodeoxynucleotides and some their 5'- and 3'-linked derivatives.
    Mazzei M; Balbi A; Grandi T; Sottofattori E; Garzoglio R; Abramova T; Ivanova E
    Farmaco; 1993 Dec; 48(12):1649-61. PubMed ID: 8135989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.